A nuclear receptor in thyroid malignancy:: is PAX8/PPARγ the Holy Grail of follicular thyroid cancer?

被引：11

作者：

Führer, D ^{[1
]}

机构：

[1] Univ Leipzig, Med Klin 3, Dept Med, D-04103 Leipzig, Germany

来源：

EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2001年 / 144卷 / 05期

关键词：

D O I：

10.1530/eje.0.1440453

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：453 / 456

页数：4

共 20 条

[1]

[Anonymous], CLIN ASPIRATION CYTO

[2]

Chang TH, 2000, CANCER RES, V60, P1129

[3]

DEMICCO C, 1991, CANCER-AM CANCER SOC, V67, P3036, DOI 10.1002/1097-0142(19910615)67:12<3036::AID-CNCR2820671218>3.0.CO

[4]

2-D

[5] Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].

Desvergne, B ;

Wahli, W .

ENDOCRINE REVIEWS, 1999, 20 (05) :649-688

[6] Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice [J].

Elstner, E ;

Müller, C ;

Koshizuka, K ;

Williamson, EA ;

Park, D ;

Asou, H ;

Shintaku, P ;

Said, JW ;

Heber, D ;

Koeffler, HP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8806-8811

[7] Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules [J].

Gasbarri, A ;

Martegani, MP ;

Del Prete, F ;

Lucante, T ;

Natali, PG ;

Bartolazzi, A .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3494-3502

[8] Changing concepts in the diagnosis and management of thyroid nodules [J].

Gharib, H .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1997, 26 (04) :777-+

[9]

GUAN YF, 1999, NEOPLASIA, V10, P330

[10] CYTOGENETIC AND MOLECULAR GENETIC-STUDIES OF FOLLICULAR AND PAPILLARY THYROID CANCERS [J].

HERRMANN, MA ;

HAY, ID ;

BARTELT, DH ;

RITLAND, SR ;

DAHL, RJ ;

GRANT, CS ;

JENKINS, RB .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1596-1604

← 1 2 →